The global depression treatment market is predicted to reach a valuation of US$ 16.8 Billion by 2032, with the market growing at a moderate CAGR of 5.2% from 2022 to 2032. Valued at US$ 9.7 Billion in 2021, the target market is expected to reach an estimated US$ 10.1 Billion in 2022. Different factors like demographic changes, …
Category Archives: Healthcare Trends
Innovative Biologic Medicines | Understanding PCSK9 Inhibitors and Their Impact on LDL Cholesterol
A recently published study by FMI expects the Global PCSK9 Inhibitors Market Demand to augment at a 15.8% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 13 Billion is expected for the market. Monoclonal antibodies are a kind of biologic medicine that inhibits PCSK9. PCSK9 Inhibitors …
Future Outlook | The Promising Frontier of Oncolytic Virus Cancer Therapy
According to a recent study published by Future Market Insights, the Market for Oncolytic Virus Cancer Therapy forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise awareness …
Continue reading “Future Outlook | The Promising Frontier of Oncolytic Virus Cancer Therapy”
Fucosidosis Therapeutics Landscape | Market Projections and Treatment Breakthroughs
The Global Fucosidosis Therapeutics Market Size is predicted to generate a market value of US$ 10 million in 2023 and a market value of US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. Fucosidosis Therapeutics market grew at a 4% CAGR between 2018 and 2022. Fucosidosis is a rare lysosomal …
Donohue Syndrome Treatment Market on the Rise | A 4% CAGR Forecast from 2023 to 2033
According to a recent FMI analysis, the global Donohue Syndrome Treatment Market Demand is expected to grow at a 4% CAGR from 2023 to 2033. The market is anticipated to be valued at US$ 25 billion by the end of the assessment period. Donohue syndrome, also known as leprechaunism, is an extremely rare and severe …
Harnessing Research | Promising Outlook for Dystrophic Epidermolysis Bullosa Treatment Market
According to Future Market Insights, the global Dystrophic Epidermolysis Bullosa Management Market will increase at a compound annual growth rate (CAGR) of 5.7% between 2023 and 2033, reaching US$ 787.8 million by 2033. With increased research to cure this illness, the global market for dystrophic epidermolysis bullosa treatment is predicted to grow significantly throughout the …
Proactive Attitude and Technology Expansion | Key Drivers for Podiatry Services Market Growth
The global Podiatry Services Market Demand is anticipated to grow at a rather staggering CAGR of 2.6% throughout the assessment period from 2022 to 2033. The global market was held at a US$ 4.6 Billion valuation in 2022 and is projected to reach US$ 6.1 Billion by 2033. General Podiatry is expected to be the …
Respiratory Disorders and Aging Population Fuel Hypoventilation Management Market Surge
The global Hypoventilation Management Market Size is estimated to achieve an amazing valuation of US$ 7.1 billion in 2023 and reach US$ 11.9 billion by 2033, growing at a 5.3% CAGR during the forecast period. Obesity may be on the rise as high-calorie foods become more popular and widely available among young people. This, in …
Analgesics Market Projected to Exhibit Significant Growth, Expected to Surge from US$ 87.3 Billion in 2023 to over US$ 132.0 Billion by 2033
According to FMI reports, the global analgesics market can soar at a rate CAGR of 4.2% from 2023-2033. The net worth of the market share of the analgesics industry is predicted to go from US$ 87.3 Mn in 2023 to over US$ 132.0 Mn by 2033. People with acute, chronic diseases such as heart disease, cancer, diabetes, …
Pneumococcal Vaccines Market is predicted to advance at a CAGR of 4.1% from 2023 to 2033
During the forecast period, a CAGR of 4.1% is expected to be achieved on average by the global market for pneumococcal vaccines. The market is currently estimated to be worth US$ 8.9 billion in 2023. By 2033, it’s expected that the market for pneumococcal vaccines will be worth more than US$ 13.3 billion. The analysts at …